as on
| Source : NSE
🔔 Regulatory Alert
Unichem Laboratories receives USFDA Establishment Inspection Report for Roha API facility, classified as Voluntary Action Initiated (VAI), indicating compliance with regulatory standards.
as on August 26, 2025 at 4:01 PM IST
Day's Low
Day's High
3.83%
Downside
5.52%
Upside
52 Week's Low
52 Week's High
8.59%
Downside
77.51%
Upside
Market Stats | |
Previous Close | ₹509.05 |
Open | ₹510.00 |
Volume | 1.75L |
Upper Circuit | ₹610.85 |
Lower Circuit | ₹407.25 |
Day's Low | ₹508.15 |
Day's High | ₹557.55 |
52 Week Low | ₹483 |
52 Week High | ₹937.95 |
Returns % | |
1 Month Return | -18.24 % |
3 Month Return | -16.51 % |
1 Year Return | -12.8 % |
3 Year Return | + 72.41 % |
5 Year Return | + 90.94 % |
Check Unichem Laboratories Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹3,584.00 Cr
Return on Equity (ROE)
6.86
PE Ratio (TTM)
28.68
Return on capital employed (ROCE)
7.58
Industry PE ratio
43.85
Beta (LTM)
0.89
P/B Ratio
1.98
Dividend Yield
0PEG Ratio
0.99
Quarterly Earnings Growth YOY
-605.8
EPS (TTM)
19.53
Sector
Pharmaceuticals
Book Value
348.1
Technical Analysis
Bearish
View Technical Analysis
Track how Unichem Laboratories Ltd P/E has moved over time to understand its valuation trends.
Unichem Laboratories Ltd in the last 5 years
Lowest (-1720.62x)
October 1, 2021
Today (28.68x)
August 25, 2025
Industry (43.85x)
August 25, 2025
Highest (1039.54x)
February 5, 2024
Today’s Price to Earnings Ratio: 28.68x
Get the annual and quarterly financial summary of Unichem Laboratories Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Unichem Laboratories Ltd.
Unichem Laboratories Ltd’s net profit fell -605.8% since last year same period to ₹-10.47Cr in the Q1 2025-2026. On a quarterly growth basis, Unichem Laboratories Ltd has generated -119.77% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2022, Unichem Laboratories Ltd has declared dividend of ₹4.00 per share on 27 May 2022 - translating a dividend yield of 1.57%.
Read More about DividendsCheck stock indices that include Unichem Laboratories Ltd.
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Unichem Laboratories Ltd.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 70.22% | 0.00 | |
Foreign Institutions | 0.98% | ||
Mutual Funds | 9.39% | ||
Retail Investors | 17.88% | 2.32 | |
Others | 1.53% | 6.68 |
Compare market cap, revenue, PE, and other key metrics of Unichem Laboratories Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 3,584.00 | 18.19% | 0.58 | 137 | 2,110 | |
NA | 325.74 | 31.96% | 0.63 | 5 | 44 | |
NA | 70.29 | 1.79% | 0.00 | 1 | 40 | |
NA | 64.20 | 1.73% | 0.00 | -5 | 10 | |
NA | 31.87 | -5.03% | 0.00 | 1 | 150 |
Latest news and events in one place to help you make informed investing decisions in Unichem Laboratories Ltd.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 17.48% to 17.88% in Jun 2025 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.4% return, outperforming this stock by 65.0%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 26.8% return, outperforming this stock by 39.6%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 70.22% of holdings in Jun 2025 quarter
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 0.98% of holdings in Jun 2025 quarter
Profit Down
Netprofit is down for the last 3 quarters, 57.85 Cr → -10.47 Cr (in ₹), with an average decrease of 64.1% per quarter
Revenue Fall
Revenue is down for the last 2 quarters, 596.43 Cr → 533.42 Cr (in ₹), with an average decrease of 10.6% per quarter
Price Dip
In the last 1 month, UNICHEMLAB stock has moved down by -18.2%
MF Holding Down
Mutual Funds have decreased holdings from 9.89% to 9.39% in Jun 2025 quarter
Organisation | Unichem Laboratories Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
CEO | Prakash A Mody |
E-voting on shares | Click here to vote |
Check out the Mutual Funds with significant holdings in Unichem Laboratories Ltd.
Unichem Laboratories Ltd share price today stands at ₹528.4, Open: ₹510, Previous Close: ₹509.05, High: ₹557.55, Low: ₹508.15, 52 Week High: ₹937.95, 52 Week Low: ₹483 as on .
To buy Unichem Laboratories Ltd shares, you need to follow these steps:
Today's traded volume of Unichem Laboratories Ltd is 1.75L. Which means that 1.75L shares of Unichem Laboratories Ltd were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Unichem Laboratories Ltd is ₹3,584.00 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Unichem Laboratories Ltd’s 52 week high is ₹937.95 and 52 week low is ₹483. The current share price of Unichem Laboratories Ltd is ₹528.4, which is -43.66% down from its 52 week high and 9.40% up from its 52 week low.